TaiGen Biopharmaceuticals Holdings Limited (TPEX:4157)
Taiwan
· Delayed Price · Currency is TWD 11.45
+0.20 (1.78%)
Mar 10, 2026, 10:19 AM CST
TPEX:4157 Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 8,008 | 8,219 | 10,911 | 11,505 | 11,039 | 16,380 | Upgrade
|
| Market Cap Growth | -3.83% | -24.67% | -5.16% | 4.22% | -32.60% | 24.19% | Upgrade
|
| Enterprise Value | 7,228 | 7,222 | 10,169 | 10,545 | 10,032 | 15,984 | Upgrade
|
| Last Close Price | 11.25 | 11.45 | 15.20 | 16.05 | 15.40 | 22.85 | Upgrade
|
| PE Ratio | - | - | 79.80 | - | 14.23 | - | Upgrade
|
| PS Ratio | 206.68 | 54.56 | 88.61 | 317.56 | 8.53 | 699.34 | Upgrade
|
| PB Ratio | 8.97 | 7.59 | 9.75 | 11.86 | 8.81 | 37.04 | Upgrade
|
| P/TBV Ratio | 8.97 | 7.68 | 9.87 | 11.86 | 8.81 | 37.07 | Upgrade
|
| P/FCF Ratio | 333671.99 | - | 3055.51 | - | 17.84 | - | Upgrade
|
| P/OCF Ratio | 16048.35 | - | 1462.83 | - | 17.55 | - | Upgrade
|
| EV/Sales Ratio | 186.54 | 47.94 | 82.59 | 291.05 | 7.75 | 682.43 | Upgrade
|
| EV/EBITDA Ratio | - | - | - | - | 11.03 | - | Upgrade
|
| EV/EBIT Ratio | - | - | - | - | 11.15 | - | Upgrade
|
| EV/FCF Ratio | 301155.36 | - | 2847.73 | - | 16.21 | - | Upgrade
|
| Debt / Equity Ratio | 0.09 | 0.05 | 0.07 | 0.04 | 0.04 | 0.04 | Upgrade
|
| Debt / EBITDA Ratio | - | - | - | - | 0.06 | - | Upgrade
|
| Debt / FCF Ratio | 3395.79 | - | 20.92 | - | 0.09 | - | Upgrade
|
| Net Debt / Equity Ratio | -0.87 | -0.89 | -0.86 | -0.89 | -0.69 | -0.71 | Upgrade
|
| Net Debt / EBITDA Ratio | 4.66 | 8.45 | 5.85 | 3.22 | -0.96 | 1.06 | Upgrade
|
| Net Debt / FCF Ratio | -32516.62 | 5.54 | -269.76 | 34.88 | -1.41 | 1.27 | Upgrade
|
| Asset Turnover | 0.04 | 0.13 | 0.11 | 0.03 | 1.33 | 0.03 | Upgrade
|
| Inventory Turnover | 0.37 | 0.42 | 0.46 | 0.23 | 0.78 | 0.36 | Upgrade
|
| Quick Ratio | 9.99 | 22.49 | 22.38 | 17.97 | 13.41 | 3.86 | Upgrade
|
| Current Ratio | 10.79 | 23.57 | 23.19 | 18.50 | 13.71 | 4.13 | Upgrade
|
| Return on Equity (ROE) | -18.36% | -3.51% | 13.09% | -21.33% | 91.47% | -64.39% | Upgrade
|
| Return on Assets (ROA) | -9.62% | -6.35% | -9.59% | -14.23% | 57.68% | -25.57% | Upgrade
|
| Return on Invested Capital (ROIC) | -134.26% | -88.22% | -125.41% | -112.72% | 311.53% | -165.06% | Upgrade
|
| Return on Capital Employed (ROCE) | -18.60% | -10.80% | -14.80% | -27.90% | 69.00% | -66.60% | Upgrade
|
| Earnings Yield | -2.30% | -0.47% | 1.25% | -2.06% | 7.03% | -2.47% | Upgrade
|
| FCF Yield | 0.00% | -2.11% | 0.03% | -0.21% | 5.61% | -1.51% | Upgrade
|
| Buyback Yield / Dilution | 0.06% | -0.03% | -0.06% | 0.07% | -0.07% | -0.01% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.